Geisinger to launch Philips eICU program

Justine Varieur Cadet | | Health Imaging | Practice Management
Royal Philips Electronics has entered into an agreement with Geisinger Health System, headquartered in Danville, Pa., to launch an eICU program.

Philips said its Visicu eICU program combines early warning alerts and remote monitoring technology to connect off-site critical care specialists with intensive care unit (ICU) patients and their bedside care teams. In the program, ICU physicians and nurses execute predefined plans or intervene in emergencies when a patient’s attending physician is not in the ICU, according to the company.

Geisinger is a healthcare system that spans 43 counties of 20,000 square miles and serves 2.6 million people.

Justine Varieur Cadet

Related Content

MRI accident has prompted the company that installed the scanner to issue a safety warning
Newly launched report feature provides patients with a visual aid to their imaging
Center for Devices and Radiological Health hit with federal job cuts
Overview of the regulatory landscape of AI in radiology
Concerns about private equity's growing influence in radiology
'Ad hoc' shifts and radiology 'maestros': How one department addressed its workflow hiccups

Around the web

Cardiovascular Business
GE HealthCare launches new cardiac CT scanner with advanced AI capabilities

GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

Cardiovascular Business
Bracco updates HeartSee coronary flow capacity software with new diagnostic features

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

Cardiovascular Business
Key trends in diagnostic heart testing: CT on the rise as some traditional techniques fall out of favor

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.